Konstantin A. Stark

Biedersteiner Str. 29
Munich, BY 80802, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 115 publications

Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.

Transcatheter Aortic Valve Replacement or Medical Treatment for Paradoxical Low-Flow, Low-Gradient Aortic Valve Stenosis: REBOOT-PARADOX.

Journal: Journal of the American College of Cardiology

Published: July 22, 2026

All-Cause Mortality Up to 20 Years After PCI or CABG for Left Main Disease.

All-Cause Mortality Up to 20 Years After PCI or CABG for Left Main Disease.

Journal: Journal of the American College of Cardiology

Published: July 14, 2026

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Dual antithrombotic therapy using potent antiplatelet inhibitors in atrial fibrillation and acute coronary syndrome: a randomized controlled trial.

Journal: Nature medicine

Published: July 02, 2026

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Development of atrioventricular valve regurgitation following transcatheter aortic valve replacement for severe aortic stenosis.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: March 30, 2026

Early Hemodynamic Valve Deterioration After TAVR: Don't Take It Lightly!

Early Hemodynamic Valve Deterioration After TAVR: Don't Take It Lightly!

Journal: JACC. Cardiovascular interventions

Published: September 02, 2025

Barthel index in TAVR patients - a novel use of an old score.

Barthel index in TAVR patients - a novel use of an old score.

Journal: Clinical research in cardiology : official journal of the German Cardiac Society

Published: July 18, 2025

Long-Term Outcomes in Valve-in-Valve TAVR: Expanding the Evidence From Registry to Practice.

Long-Term Outcomes in Valve-in-Valve TAVR: Expanding the Evidence From Registry to Practice.

Journal: JACC. Cardiovascular interventions

Published: July 04, 2025

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

Immunological risk identified by single-cell multi-omics and cardiovascular outcomes.

Journal: European heart journal

Published: June 01, 2025

Thromboembolic Risk among Patients on Dual Antiplatelet Therapy with or without Heparin Thromboprophylaxis.

Thromboembolic Risk among Patients on Dual Antiplatelet Therapy with or without Heparin Thromboprophylaxis.

Journal: Thrombosis and haemostasis

Published: May 19, 2025

Recent Advances in Immunothrombosis and Thromboinflammation.

Recent Advances in Immunothrombosis and Thromboinflammation.

Journal: Thrombosis and haemostasis

Published: May 01, 2025

Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression.

Neutrophil-Driven Trogocytosis in Pancreatic Ductal Adenocarcinoma Liver Metastases Restrains Immunosuppressive Macrophage Polarization and Limits Metastatic Progression.

Journal: Gastroenterology

Published: February 28, 2025

NGAL: a new link between thrombosis and hemostasis.

NGAL: a new link between thrombosis and hemostasis.

Journal: Blood

Published: February 27, 2025

Showing 1-12 of 115

Last Updated: 09/26/2026